Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Joshua

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Hematological Oncology|February 28, 2003
T cells in myelomaM Raitakari, R D Brown, J Gibson, et al.
Leukemia & Lymphoma|July 27, 2016
CD10-(CALLA)-Positive Lymphocytes in Myeloma: Evidence that they are a Malignant Precursor Population and are of Germinal Centre OriginP Warburton, D E Joshua, J Gibson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1991
Aseptic meningitis associated with high dose intravenous immunoglobulin therapyJ D Watson, J Gibson, D E Joshua, et al.
British Journal of Haematology|June 1, 1992
Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myelomaM Nelson, R D Brown, J Gibson, et al.
Pathology|October 1, 1985
Monoclonal antibodies to human FVIIIR:Ag and FVIIICS E Francis, D E Joshua, T Exner, et al.
British Journal of Haematology|September 1, 1987
Multiple myeloma: the relationship between CALLA (CD10) positive lymphocytes in the peripheral blood and light chain isotype suppressionA J Wearne, D E Joshua, R D Brown, et al.
Blood|August 1, 1996
Circulating clonal lymphocytes in myeloma determined by mRNA in situ hybridizationD E Joshua, R D Brown, X F Luo, et al.
European Journal of Haematology|January 1, 1987
Multiple myeloma: light chain isotype suppression--a marker of stable disease at presentationA J Wearne, D E Joshua, G A Young, et al.
Australian and New Zealand Journal of Medicine|June 1, 1989
Serum thymidine kinase as a marker of disease activity in patients with multiple myelomaR D Brown, D E Joshua, R A Ioannidis, et al.
Transfusion|July 1, 1988
Positive direct antiglobulin test in acute leukemia at presentationJ Gibson, J Wells, R Holdsworthy, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Hematological Oncology|February 28, 2003
T cells in myelomaM Raitakari, R D Brown, J Gibson, et al.
Leukemia & Lymphoma|July 27, 2016
CD10-(CALLA)-Positive Lymphocytes in Myeloma: Evidence that they are a Malignant Precursor Population and are of Germinal Centre OriginP Warburton, D E Joshua, J Gibson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1991
Aseptic meningitis associated with high dose intravenous immunoglobulin therapyJ D Watson, J Gibson, D E Joshua, et al.
British Journal of Haematology|June 1, 1992
Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myelomaM Nelson, R D Brown, J Gibson, et al.
Pathology|October 1, 1985
Monoclonal antibodies to human FVIIIR:Ag and FVIIICS E Francis, D E Joshua, T Exner, et al.
British Journal of Haematology|September 1, 1987
Multiple myeloma: the relationship between CALLA (CD10) positive lymphocytes in the peripheral blood and light chain isotype suppressionA J Wearne, D E Joshua, R D Brown, et al.
Blood|August 1, 1996
Circulating clonal lymphocytes in myeloma determined by mRNA in situ hybridizationD E Joshua, R D Brown, X F Luo, et al.
European Journal of Haematology|January 1, 1987
Multiple myeloma: light chain isotype suppression--a marker of stable disease at presentationA J Wearne, D E Joshua, G A Young, et al.
Australian and New Zealand Journal of Medicine|June 1, 1989
Serum thymidine kinase as a marker of disease activity in patients with multiple myelomaR D Brown, D E Joshua, R A Ioannidis, et al.
Transfusion|July 1, 1988
Positive direct antiglobulin test in acute leukemia at presentationJ Gibson, J Wells, R Holdsworthy, et al.
Pageof 9